Cidara Therapeutics Inc CDTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
12.51quote price arrow down-0.17 (-1.34%)
Volume
53,699
52 week range
10.00 - 29.60
Loading...
  • Open11.75
  • Day High13.20
  • Day Low11.75
  • Prev Close12.68
  • 52 Week High29.60
  • 52 Week High Date05/23/23
  • 52 Week Low10.00
  • 52 Week Low Date04/23/24

Key Stats

  • Market Cap57.067M
  • Shares Out4.56M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change-21.22

KEY STATS

  • Open11.75
  • Day High13.20
  • Day Low11.75
  • Prev Close12.68
  • 52 Week High29.60
  • 52 Week High Date05/23/23
  • 52 Week Low10.00
  • 52 Week Low Date04/23/24
  • Market Cap57.067M
  • Shares Out4.56M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change-21.22

RATIOS/PROFITABILITY

  • EPS (TTM)-5.06
  • P/E (TTM)-2.47
  • Fwd P/E (NTM)-4.60
  • EBITDA (TTM)-24.365M
  • ROE (TTM)-366.84%
  • Revenue (TTM)63.905M
  • Gross Margin (TTM)45.03%
  • Net Margin (TTM)-35.88%
  • Debt To Equity (MRQ)-9.66%

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cidara Therapeutics Inc

 

Profile

MORE
Cidara Therapeutics, Inc. is a biotechnology company. The Company is developing targeted immunotherapies designed for patients facing serious diseases. The Company’s portfolio comprises various treatment and prevention paradigms, including drug-Fc conjugate (DFC) from its Cloudbreak platform targeting oncologic, viral and autoimmune diseases. The Company is focused on advancing Cloudbreak development programs, including its lead oncology candidate, CBO421, as well as...
Daniel Burgess
Independent Chairman of the Board
Jeffrey Stein Ph.D.
President, Chief Executive Officer, Director
Shane Ward
Chief Operating Officer, Company Secretary
Preetam Shah Ph.D.
Chief Financial Officer, Chief Business Officer
Address
6310 Nancy Ridge Dr Ste 101
San Diego, CA
92121-3209
United States

Top Peers

SYMBOLLASTCHG%CHG
PSNL
Personalis Inc
1.54-0.06-3.75%
RDHL
Redhill Biopharma Ltd
0.4499-0.0006-0.1332%
HLTH
Cue Health Inc
0.14UNCHUNCH
MTEM
Molecular Templates Inc
1.67-0.06-3.19%
DTIL
Precision BioSciences Inc
10.52-0.32-2.95%